Trial intelligence / Profile preview

Phase IIa open-label study of NH600001 emulsion injection for induction and maintenance of general anesthesia in elective surgery

CTR20263052Phase 2Active

Sponsor
Jiangsu Nhwa Pharmaceutical
Start
Aug 2026
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of NH600001 in general anesthesia, sponsored by Jiangsu Nhwa Pharmaceutical. Started Aug 2026; status: active.

02

Drugs

NH600001
03

Conditions

general anesthesia

Beyond the preview

Go deeper on CTR20263052.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20263052.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call